These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

667 related items for PubMed ID: 27189458

  • 21. Evaluation of changes in choroidal neovascularization secondary to age-related macular degeneration after anti-VEGF therapy using spectral domain optical coherence tomography.
    You JY, Chung H, Kim HC.
    Curr Eye Res; 2012 May; 37(5):438-45. PubMed ID: 22510011
    [Abstract] [Full Text] [Related]

  • 22. Retinal and choroidal thickness changes after single anti-VEGF injection in neovascular age-related macular degeneration: ranibizumab vs bevacizumab.
    Sizmaz S, Kucukerdonmez C, Kal A, Pinarci EY, Canan H, Yilmaz G.
    Eur J Ophthalmol; 2014 May; 24(6):904-10. PubMed ID: 24803153
    [Abstract] [Full Text] [Related]

  • 23. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
    Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W, Davis JL, Flynn HW, Esquiabro M.
    Am J Ophthalmol; 2009 Jul; 148(1):43-58.e1. PubMed ID: 19376495
    [Abstract] [Full Text] [Related]

  • 24. Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration.
    Yun C, Oh J, Choi KE, Hwang SY, Kim SW, Huh K.
    BMC Ophthalmol; 2016 Mar 08; 16():25. PubMed ID: 26951107
    [Abstract] [Full Text] [Related]

  • 25. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K, Zlabinger GJ, Schmidt-Erfurth U.
    Ophthalmology; 2009 Dec 08; 116(12):2393-9. PubMed ID: 19815292
    [Abstract] [Full Text] [Related]

  • 26. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN, Mendrinos E, Mangioris G, Donati G, Pournaras CJ.
    Ophthalmology; 2009 Sep 08; 116(9):1755-61. PubMed ID: 19560206
    [Abstract] [Full Text] [Related]

  • 27. A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration.
    Boyer DS, Heier JS, Brown DM, Francom SF, Ianchulev T, Rubio RG.
    Ophthalmology; 2009 Sep 08; 116(9):1731-9. PubMed ID: 19643495
    [Abstract] [Full Text] [Related]

  • 28. Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration.
    Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Kawasaki R, Sekiryu T, Okada AA, Iida T.
    Am J Ophthalmol; 2015 Apr 08; 159(4):627-33. PubMed ID: 25555799
    [Abstract] [Full Text] [Related]

  • 29. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jirarattanasopa P, Ooto S, Nakata I, Tsujikawa A, Yamashiro K, Oishi A, Yoshimura N.
    Invest Ophthalmol Vis Sci; 2012 Jun 14; 53(7):3663-72. PubMed ID: 22570352
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA, Pan-American Collaborative Retina Study Group.
    Retina; 2008 Jun 14; 28(10):1387-94. PubMed ID: 18827735
    [Abstract] [Full Text] [Related]

  • 34. A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration.
    Jaffe GJ, Eliott D, Wells JA, Prenner JL, Papp A, Patel S.
    Ophthalmology; 2016 Jan 14; 123(1):78-85. PubMed ID: 26499921
    [Abstract] [Full Text] [Related]

  • 35. Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial.
    Abdelfattah NS, Al-Sheikh M, Pitetta S, Mousa A, Sadda SR, Wykoff CC, Treat-and-Extend Age-Related Macular Degeneration Study Group.
    Ophthalmology; 2017 Feb 14; 124(2):215-223. PubMed ID: 27863845
    [Abstract] [Full Text] [Related]

  • 36. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H, Ji B, Chung H, Kim HC.
    Retina; 2016 Mar 14; 36(3):465-75. PubMed ID: 26076214
    [Abstract] [Full Text] [Related]

  • 37. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY.
    Sarao V, Parravano M, Veritti D, Arias L, Varano M, Lanzetta P.
    Retina; 2016 Apr 14; 36(4):770-7. PubMed ID: 26398691
    [Abstract] [Full Text] [Related]

  • 38. Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration.
    Rothenbuehler SP, Waeber D, Brinkmann CK, Wolf S, Wolf-Schnurrbusch UE.
    Am J Ophthalmol; 2009 May 14; 147(5):831-7. PubMed ID: 19217019
    [Abstract] [Full Text] [Related]

  • 39. EFFECT OF INTRAVITREAL RANIBIZUMAB ON GANGLION CELL COMPLEX AND PERIPAPILLARY RETINAL NERVE FIBER LAYER IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION USING SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.
    Zucchiatti I, Cicinelli MV, Parodi MB, Pierro L, Gagliardi M, Accardo A, Bandello F.
    Retina; 2017 Jul 14; 37(7):1314-1319. PubMed ID: 28574419
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H, Ventura AA, Chung JY, Sharma S, Kaiser PK.
    Ophthalmology; 2009 Sep 14; 116(9):1740-7. PubMed ID: 19643484
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.